Arsenic-induced inflammation in workers

被引:0
|
作者
Lutfiye Tutkun
Meside Gunduzoz
Vugar Ali Turksoy
Serdar Deniz
Ozgur Oztan
Sultan Pınar Cetintepe
Servet Birgin Iritas
Fatma Meric Yilmaz
机构
[1] Yozgat BozokUniversity,Department of Biochemistry, Faculty of Medicine
[2] Ankara Occupational Diseases Hospital,Department of Family Medicine
[3] Yozgat Bozok University,Department of Public Health, Faculty of Medicine
[4] Provincial Health Directorate,Department of Medical Management
[5] HLC Medical Center,Department of Internal Medicine, Faculty of Medicine
[6] Hacettepe University,The Council of Forensic Medicine
[7] Ministry of Justice,Department of Medical Biochemistry, Faculty of Medicine
[8] Ankara Yildirim Beyazit University,undefined
来源
Molecular Biology Reports | 2019年 / 46卷
关键词
Inflammation; Cytokine levels; Selenium; Zinc;
D O I
暂无
中图分类号
学科分类号
摘要
Occupational and environmental exposures to metal and metalloids can result in neurotoxicity and immunotoxicity. Selenium (Se) is essential for the proper functioning of neutrophils, macrophages, natural killer (NK) cells, T-lymphocytes and other immune mechanisms, while zinc (Zn) is a trace element essential for basic cell activities, including cell growth and differentiation. Arsenic (As) may lead to different types of immunosuppressive effects. This study consisted of 62 male workers, who had been exposed to arsenic for different durations and 73 non-exposed male workers (control group) with no history of occupational toxic metal exposure. Whole blood and serum samples were taken from each participant for immunological, toxicological and routine analysis during their annual periodical examination. Arsenic, selenium and zinc levels were determined by the ICP-MS and cytokines, IL-6, IL-10, TNF-α, sE-selectin and VCAM-1, were measured by ELISA. There were statistically significant differences (p < 0.001) between control and As-exposed group in As (1.37 ± 0.42 vs. 4.27 ± 1.54 µg/L) and Se levels (106.37 ± 48.04 vs. 74.70 ± 30.45 µg/L). The changing levels of As, Zn and Se seems to affect the severity of inflammatory reactions based on IL-6, IL-10 and TNF-α levels (r = 0.755, r = 0.679 and r = 0.617, respectively, for all p < 0.01). Selenium was found to have a suppressive effect on cytokines, as evidenced by Pearson correlations and regression analysis. These findings support the need to closely monitor Se levels in individuals exposed to arsenic and benefits for Se supplementation in the case of arsenic exposure, occupationally or environmentally.
引用
收藏
页码:2371 / 2378
页数:7
相关论文
共 50 条
  • [41] Micronuclei assay to detect arsenic-induced cancer
    Sharma, DC
    LANCET ONCOLOGY, 2004, 5 (07): : 393 - 393
  • [42] Signaling mechanisms for arsenic-induced vascular disease
    Soucy, NV
    Klei, LR
    Barchowsky, A
    FREE RADICAL BIOLOGY AND MEDICINE, 2002, 33 : S351 - S352
  • [43] Arsenic-induced skin cancers: pathomechanisms of aneuploidy
    Chang, C.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2012, 132 : S42 - S42
  • [44] Molecular features in arsenic-induced lung tumors
    Hubaux, Roland
    Becker-Santos, Daiana D.
    Enfield, Katey S. S.
    Rowbotham, David
    Lam, Stephen
    Lam, Wan L.
    Martinez, Victor D.
    MOLECULAR CANCER, 2013, 12
  • [45] Arsenic-induced alterations in contact hypersensitivity.
    Patterson, RM
    Vega-Lloyo, L
    Trouba, KJ
    Teague, JA
    Germolec, DR
    TOXICOLOGICAL SCIENCES, 2003, 72 : 376 - 377
  • [46] Arsenic-induced APL differentiation in cerebrospinal fluid
    Helwig, Annett
    Klemm, Matthias
    Schuettig, Reinhard
    Roellig, Christoph
    Wassilew, Nasstasja
    Ehninger, Gerhard
    Illmer, Thomas
    LEUKEMIA RESEARCH, 2007, 31 (05) : 703 - 705
  • [47] Arsenic-Induced Carcinogenesis: The Impact of miRNA Dysregulation
    Cardoso, Ana P. Ferragut
    Al-Eryani, Laila
    States, J. Christopher
    TOXICOLOGICAL SCIENCES, 2018, 165 (02) : 284 - 290
  • [48] Arsenic-induced bladder cancer in an animal model
    Cohen, Samuel M.
    Ohnishi, Takamasa
    Arnold, Lora L.
    Le, X. Chris
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2007, 222 (03) : 258 - 263
  • [49] ARSENIC-INDUCED TORSADE-DE-POINTES
    BECKMAN, KJ
    BAUMAN, JL
    PIMENTAL, PA
    GARRARD, C
    HARIMAN, RJ
    CRITICAL CARE MEDICINE, 1991, 19 (02) : 290 - 292
  • [50] Arsenic-induced keratoses and Bowen's disease
    Watson, K
    Creamer, D
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2004, 29 (01) : 46 - 48